May 20, 2019 / 08:30PM GMT
Operator
Greetings and welcome to Innovate analyst event conference call. I would now like to turn the conference over to your host, Jen Zimmons. Thank you. You may begin.
Jennifer K. Zimmons - Strategic Growth International, Inc. - MD
Good afternoon, ladies and gentlemen, and welcome to the Innovate Biopharmaceuticals DDW 2019 Analyst Event. As a reminder, this call is being recorded and webcasted. Joining our call are Dr. Stephen Harris (sic) [Harrison], a leading clinical investigator in NASH; Dr. Laumas, our Chairman and CEO; and Dr. Griffin, our Chief Medical Officer.
Before we begin, I'd like to remind everyone that this conference call includes forward-looking statements. Each forward-looking statement contained in this call is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information regarding these factors are described in the risk factors and management's discussion and analysis section of our most recent quarterly and annual financial reports. The forward
Innovate Biopharmaceuticals Inc Analyst Event to Discuss NASH Data and Provide Clinical Updates Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers